[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.202.44. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1969

Adult Women Vaccinated With Rubella Vaccine: A Preliminary Report on Controlled Studies With Cendehill Strain

Author Affiliations

Philadelphia; Genval, Belgium; Philadelphia
From the Smith, Kline & French Laboratories, Philadelphia (Drs. Gold and McKee), and Recherche et Industrie Thérapeutiques, Genval, Belgium (Dr. Prinzie).

Am J Dis Child. 1969;118(2):264-265. doi:10.1001/archpedi.1969.02100040266022
Abstract

IN JUNE 1968, Cooper and Krugman1 observed transient arthritis in women receiving the dog kidney-adapted derivative of HPV-77. Subsequently, Stokes et al2 reported 15 cases of arthralgia and arthritis reactions in 35 susceptible adult women vaccinated with HPV-77 rubella vaccine passed five times in duck embryo (DE) cell culture. These reactions were rated as mild to severe and included one case in which rubella virus was isolated from an affected knee joint. Extending these observations, Cooper et al3 reported 14 cases of arthralgia and arthritis manifestations, ranging from mild to severe, in 25 seronegative adult women vaccinated with HPV-77 DK12 rubella vaccine, and four mild arthralgic reactions in 13 adult women vaccinated with Cendehill rubella vaccine. In a comparative study by Horstmann et al,4 utilizing HPV-77 DE5 plus γ-globulin and Cendehill vaccine alone in seronegative adult women, arthritic manifestations were noted in four of 12

×